Bavarian Nordic (BVNRY) 51.7500 $BVNRY Bavarian Nordic

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bavarian Nordic (BVNRY) 51.7500 $BVNRY

Bavarian Nordic reports successful results from two studies of Imvamune smallpox vaccine
Seeking Alpha - at Seeking Alpha - Wed May 13, 8:39AM CDT


Bavarian Nordic awash in money to fund Ebola and prostate cancer programs
Seeking Alpha - at Seeking Alpha - Tue May 12, 11:13AM CDT

JNJ: 102.30 (+0.47), BMY: 67.64 (+0.19)

Why Investors Shouldn't Worry About Explosive New Drug Pricing: Maxim's Jason Kolbert
Life Sciences Report - Seeking Alpha - Thu Apr 09, 4:59PM CDT
It's the daring Phase 2-stage molecules of today that will bring patients a generation of biotech drugs that could cure certain deadly diseases tomorrow. The candidates that succeed will also energize the portfolios of investors who have exercised...
PSTI: 2.92 (+0.24), NBS: 2.38 (+0.07), OSIR: 17.29 (-0.18), BCLI: 3.66 (-0.04), MDVN: 122.90 (-0.47), INO: 7.97 (-0.02), CYTX: 0.66 (-0.02), STEM: 0.62 (unch), JUNO: 43.50 (+0.13), ATHX: 1.27 (-0.01), CUR: 1.70 (-0.04), BLUE: 154.42 (-2.98), VRTX: 126.21 (+3.21), AMGN: 162.36 (+0.38), KERX: 10.35 (+0.02), OMER: 20.88 (-0.01), KITE: 50.50 (+0.48), GILD: 109.45 (+0.15), MRK: 60.21 (-0.02), TEVA: 59.72 (-0.51)

WHO approves rapid test for Ebola
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 6:15AM CST

BCRX: 10.75 (+0.20), TKMR: 13.94 (+0.09), GSK: 44.56 (-0.21), INO: 7.97 (-0.02), JNJ: 102.30 (+0.47), CMRX: 40.15 (+0.31), NVAX: 8.54 (-0.09), HEB: 0.26 (+0.01), MRK: 60.21 (-0.02), SRPT: 15.40 (+0.19), NLNK: 39.69 (+1.57), ABIO: 0.84 (unch), IBIO: 0.89 (+0.04)

Novavax starts early stage Ebola vaccine trial
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 12:18PM CST

JNJ: 102.30 (+0.47), NVAX: 8.54 (-0.09), MRK: 60.21 (-0.02), NLNK: 39.69 (+1.57), GSK: 44.56 (-0.21)

Johnson & Johnson announces Ebola vaccine development consortia
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 7:54AM CST

JNJ: 102.30 (+0.47), MRK: 60.21 (-0.02), NLNK: 39.69 (+1.57), GSK: 44.56 (-0.21)

J&J begins Ebola vaccine trial in U.K.
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:07AM CST

JNJ: 102.30 (+0.47)

Ebola: Search For A Vaccine On The Fast Track
Tony Daltorio - at Seeking Alpha - Mon Oct 27, 11:39AM CDT

JNJ: 102.30 (+0.47), NLNK: 39.69 (+1.57), GSK: 44.56 (-0.21)

Wall Street Breakfast: Bank Of England Keeps Rates Low
Wall Street Breakfast - Seeking Alpha - Wed Oct 22, 5:32AM CDT
Economy The majority of the Bank of England's Monetary Policy Committee remains against raising interest rates, voting 7-2 to maintain a record low rate of 0.5%, minutes from the October 7-8 meeting show. The minutes said that for most members,...
TSLA: 246.81 (-2.03), F: 15.47 (-0.01), SNE: 32.74 (unch), TM: 139.20 (-0.17), WBS: 37.46 (-0.60), JNJ: 102.30 (+0.47), SPY: 212.11 (-0.33), IBM: 173.26 (-0.79), EMC: 26.88 (-0.15), AYR: 25.28 (+0.05), HMC: 35.00 (-0.08), AAPL: 128.50 (-0.27), CSCO: 29.45 (-0.10), BOND: 107.84 (+0.52), FCAU: 15.32 (-0.13), QQQ: 109.30 (-0.28), TOT: 52.88 (-0.67), ARTX: 2.59 (+0.02), GM: 34.99 (+0.08)

Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN(R) Ebola Vaccine
GlobeNewswire - Wed Oct 22, 1:06AM CDT
Bavarian Nordic A/S (OMX:BAVA) (OTC:BVNRY) announced today a global license and supply agreement for its MVA-BN Filovirus (Ebola and Marburg) vaccine candidate with Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
JNJ: 102.30 (+0.47)

Bavarian Nordic Receives Order From the Canadian Government to Supply IMVAMUNE(R) Smallpox Vaccine
GlobeNewswire - Tue Aug 26, 1:08AM CDT
Bavarian Nordic A/S (OMX:BAVA) (OTC:BVNRY) announced today that it has signed two contracts with the Canadian authorities for the delivery of a total of 65,700 doses of IMVAMUNE smallpox vaccine. The vaccines will be delivered in 2014 and 2015. This will bring the current number of delivered doses of IMVAMUNE to Canada above 100,000 doses.

Bavarian Nordic Announces First Patient Treated in a Phase 1 Study of MVA-BN(r) Brachyury in Advanced Cancer
GlobeNewswire - Thu Jul 24, 12:57AM CDT
Bavarian Nordic A/S (OMX:BAVA) (OTC:BVNRY) announced today that the first patient has been treated in an NCI-sponsored Phase 1 study of MVA-BN Brachyury in patients with advanced cancer.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HARIBO Unveils Five Boldly Colored Gummies

Updated Category News Views 184

HARIBO's New Fruity Lineup: A Sweet Adventure Hey folks, grab a bag of these new HARIBO gummies, and you're in for a fruity ride. The candy maker's got a new trick up its sleeve with five whimsical, boldly colored gummies. They've dubbed these little treats single-flavor goodies—each with one distinct shape and taste. It's a marketing move that screams 'collect them...

Continue Reading
Taiwan TPU Innovations Headline at COMPAMED 2026

Updated Category News Views 53

A Strong Showing from ICP DAS-BMP at COMPAMED 2026 You've got ICP DAS-BMP, a name steadily carving its niche in the medical grade thermoplastic polyurethane (TPU) arena, ready to put on a performance at the upcoming COMPAMED 2026. Taking place this November at the Messe Düsseldorf, it's where innovation meets medical tech, and ICP DAS-BMP is flexing its muscles,...

Continue Reading
Nexus Capital Buys Coldwater Creek, Eyes Growth Surge

Updated Category News Views 121

A New Chapter in Apparel Investment You know when you're flipping through those catalog pages or hitting up e-commerce sites, just to find that perfect piece of clothing for a special someone—and you stick with a brand not just outta habit, but 'cause they've got a piece of your history? That's Coldwater Creek and Soft Surroundings, two brands that's been keepin' their...

Continue Reading
Infiterra Streamlines Subscription Commerce for MSPs

Updated Category News Views 84

Revolutionizing How MSPs Navigate Subscription Commerce Just when you thought subscription commerce for IT might plateau, Infiterra's stepping up with some slick integration magic. They're rolling out tools that are about to make life a lot easier for Managed Service Providers (MSPs) and IT distributors. Yeah, the technological world spins fast, and these folks want in on...

Continue Reading
Akash to Leverage Solana for AI Boom

Updated Category News Views 28

Akash's Bold Move: Embracing Solana Never thought I'd see a day where Akash Network would toss its hat in with Solana. An unexpected power play, but not without reason. By moving their decentralized compute marketplace to Solana, they aim to leverage one of the slickest blockchain ecosystems around. It's like swapping a four-cylinder for a V8 – there's a potential for...

Continue Reading
ADIPEC 2026: Energy and AI Steal the Spotlight

Updated Category News Views 64

Unveiling the Future at ADIPEC 2026 ADIPEC 2026 kicked off with the kind of fanfare you'd expect only from a heavyweight gathering at the intersection of energy, AI, and investment strategy. Dr. Sultan Al Jaber and Sam Altman, two bigwigs in their fields, stood front and center to point out the latest priorities shaping these industries. And let me tell you, it's a wild...

Continue Reading
Hill Climb Racing 2's Decade of Battles and Joyrides

Updated Category News Views 132

There's something to be said for a game that sticks around for a full decade. Yeah, Hill Climb Racing 2 isn't just turning another year older—it's celebrating ten years on the scene, and Finnish developer Fingersoft is pulling out all the stops. Let's not mince words; keeping a mobile game alive and well-loved isn't easy, especially now when the app stores are packed...

Continue Reading
New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 90

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
UFC Gym Expands, Opening Murfreesboro Location Soon

Updated Category News Views 137

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 78

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading

Top 5 Most Recently Viewed Articles

ICEYE Unveils Tactical Access: Revolutionizing Satellite Surveillance

Updated Category News Views 252

Introducing Tactical Access from ICEYE ICEYE has launched Tactical Access, an innovative service that guarantees satellite imaging slots for time-sensitive missions. This groundbreaking offering prioritizes the needs of defense and intelligence organizations by ensuring they receive crucial imagery exactly when and where it is required. What is Tactical Access? Tactical...

Continue Reading
Rubicon Organics Plans to Boost Growth with New Offering

Updated Category News Views 238

Rubicon Organics Announces Private Placement for Growth Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), a notable name in the organic cannabis market, has unveiled plans for a private placement aimed at raising essential capital for its expansion initiatives. This offering involves the issuance of up to 6,818,182 units, with an expected total gross revenue of up to...

Continue Reading
Addus HomeCare Achieves Record Stock Price of $134.81

Updated Category News Views 77

Addus HomeCare Reaches New Stock Price Milestone Addus HomeCare Corporation (ADUS), a major player in the home care services industry, has achieved a remarkable milestone by seeing its stock price hit an unprecedented high of $134.81. This achievement not only reflects the company's solid performance but also underscores the confidence investors have in its strategic...

Continue Reading
Investigation into MoonLake Immunotherapeutics by Faruqi Law

Updated Category News Views 218

Faruqi & Faruqi Investigates Potential Claims Faruqi & Faruqi, LLP is currently looking into the situation surrounding MoonLake Immunotherapeutics (NASDAQ: MLTX). Investors who incurred losses are encouraged to reach out directly to discuss their rights and possible courses of action. This firm is known for its strong record in securities litigation, providing much-needed...

Continue Reading
Aker Solutions Reports Impressive Third-Quarter Growth

Updated Category News Views 199

Aker Solutions Posts Strong Third-Quarter Results Aker Solutions has once again demonstrated its strong financial performance in the latest quarter, with notable increases in revenue, margins, and cash flow compared to the same time last year. The company's positive outlook is underlined by a substantial order backlog and vigorous activity in securing new tenders across...

Continue Reading